New drug aims to stop deadly clots without causing bleeding
Disease control
Terminated
This study tested a new drug, VLX-1005, for people suspected of having heparin-induced thrombocytopenia (HIT), a serious reaction to the common blood thinner heparin that causes low platelets and dangerous clots. Participants received the current standard treatment and were rando…
Phase: PHASE2 • Sponsor: Veralox Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC